Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment…
SINGAPORE, Oct. 9, 2025 /PRNewswire/ -- Pioneering Swiss luxury watchmaker Hublot has announced the latest evolution in its ongoing partnership with…